Research Training Program in Molecular and Cellular Hematology

这项新提议的目标是使用互动、协作、多学科的方法来培训 有才华的年轻内科科学家(医学和医学博士)或博士科学家在 血液学调查研究。开发这个项目的理由是我们相信西奈山 医学院在卓越的研究环境中提供多样化的科学机会，我们 有一支致力于为学术生涯培养科学家和内科科学家的教职员工 血液学、干细胞生物学和再生医学，我们希望对 未来研究血液学家的教育。来自不同领域的教职员工都加入了这个项目。 各系和研究所以及洛克菲勒大学。这笔培训补助金的候选人将是 预计至少两年在基础血液学或转化性血液学方面的培训。实习生将 从该计划涵盖的八个广泛领域中选择一位导师：正常和恶性 造血，发育中的造血，成人和胚胎干细胞研究，信号分析 血液学过程中的途径、细胞在造血组织内的黏附和迁移 血管系统，正常凝血和遗传性凝血障碍，免疫细胞发育和功能，以及 细胞和基因治疗以及移植。在整个培训期间，学员将至少投入90% 他们的研究时间。学员将在一个人的指导下专注于一个个性化的研究项目 或者更多的教员教官。此外，他们将参加每周一次的实验室会议，花一部分时间 他们参加特定的部门、部门和机构研究会议的时间，并将 在第一年和第二年的培训中，参加讲授的研究生水平的课程。以及 血液学和内科肿瘤科研究组合的巨大增长 在过去的十年里，我们招聘了新的教师，我们现在处于非常有利的地位，可以提供 特殊的培训机会，应该会吸引许多希望 在纽约市从事血液学学术研究。 CRELEVANCE(请参阅说明)： T32奖项对于我们制定与高水平的 我们的教职员工。拟议的培训计划将扩大训练有素的分子和 通过延长该机构现有的研究培训机会进行细胞血液学研究，并将有助于 培养出一些血液学和干细胞生物学研究的未来领导者。

The objective of this new proposal is to use an interactive, collaborative, multidisciplinary approach to train talented young physician-scientists (MD and MD PhD) or PhD scientists for a successful career in investigative hematology research. The rationale for developing this program is our belief that Mount Sinai School of Medicine offers diverse scientific opportunities in an outstanding research environment, that we have a faculty that is dedicated to training scientists and physician-scientists for a career in academic hematology, stem cell biology, and regenerative medicine, and that we wish to have an impact on the education of future investigative hematologists. Faculty have been integrated into this program from various departments and institutes and from the Rockefeller University. Candidates for this training grant will be expected to devote a minimum of two years to training in basic or translational hematology. The trainees will select a mentor from one of the eight broad areas encompassed by this program: normal and malignant hematopoiesis, developmental hematopoiesis, adult and embryonic stem cell research, analysis of signaling pathways in hematologic processes, cell adhesion and migration within hematopoietic tissues and the vasculature, normal coagulation and inherited clotting disorders, immune cell development and function, and cell and gene therapy and transplantation. Throughout the training period, trainees will devote at least 90% of their time to research. Trainees will focus on an individualized research project under the guidance of one or more faculty preceptors. In addition, they will participate in weekly laboratory meetings, spend a portion of their time attending specific divisional, departmental and institutional research-oriented conferences, and will enroll in didactic, graduate level courses during the first and second years of training. Along with the enormous growth in the research portfolio of the Division of Hematology and Medical Oncology and the recruitment of new faculty over the past decade, we are now in a very strong position to provide an exceptional training opportunity that should be a magnet for the many outstanding trainees who wish to pursue a career in academic hematology research in New York City. cRELEVANCE (See instructions): A T32 award is essential for us to develop a training program that is commensurate with the high caliber of our faculty. The proposed training program will expand the pool of well-trained researchers in molecular and cellular hematology by extending the existing research training opportunities at this institution and will help produce some of the future leaders in hematology and stem cell biology research.